Projekt

Phase 3 Randomized Study of DS-1062A Versus Docetaxel in Priviously Treated Advanced or Metastatic Non-Small Cell Lung Cancer without Actionable Genomic Alterations (TROPION-LUNG01)

Laufend - Rekrutierung – laufend · 2021 bis 2099